Real-world feasibility of adjuvant TAC with pegylated G-CSF in resectable breast cancer: A single-center experience

被引：0
|
作者：
Park, J. H. [1 ]
Kwon, B. [2 ]
Ahn, J-H. [1 ]
Kim, J. E. [1 ]
Jung, K. H. [1 ]
Gong, G. [3 ]
Lee, H. J. [3 ]
Son, B-H. [4 ]
Ahn, S-H. [4 ]
Kim, H-H. [5 ]
Shin, H. J. [5 ]
Moon, D. [6 ]
Kim, S. B. [1 ]
机构：
[1] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Internal Med, Asan Med Ctr, Coll Med, Seoul, South Korea
[3] Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea
[4] Univ Ulsan, Dept Surg, Asan Med Ctr, Coll Med, Seoul, South Korea
[5] Univ Ulsan, Dept Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea
[6] Univ Ulsan, Dept Nucl Med, Asan Med Ctr, Coll Med, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
487P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world outcomes and toxicity of adjuvant chemotherapy in NSCLC: a single-center experience
    Cronin, Christopher
    Iqbal, Shahid
    Farooq, Abdul R.
    O'Dea, Pauline
    Burke, Louise
    O'Reilly, Seamus
    O'Mahony, Deirdre
    Power, Derek G.
    Bambury, Richard M.
    Collins, Dearbhaile C.
    LUNG CANCER MANAGEMENT, 2023, 12 (01)
  • [2] Biosimilar medicines in oncology: Single-center experience with biosimilar G-CSF
    Salesi, Nello
    Di Cocco, Barbara
    Veltri, Enzo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF
    Salesi, Nello
    Di Cocco, Barbara
    Colonna, Maria
    Veltri, Enzo
    FUTURE ONCOLOGY, 2012, 8 (05) : 625 - 630
  • [4] The effectiveness of adjuvant treatment approaches for resectable esophageal cancer: A single-center experience
    Algin, Efnan
    Esen, Selin Akturk
    Acikgoz, Yusuf
    Bal, Oznur
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (07) : 2018 - 2024
  • [5] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Marwan Sheikh-Taha
    American Journal of Cardiovascular Drugs, 2019, 19 : 59 - 64
  • [6] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Sheikh-Taha, Marwan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (01) : 59 - 64
  • [7] Real-world experience of abemaciclib for adjuvant and metastatic breast cancer
    Drowne, Taylor
    Armgardt, Emily
    Svoboda, Alison
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (01) : 141 - 146
  • [8] PARP INHIBITOR MAINTENANCE IN PLATINUMSENSITIVE OVARIAN CANCER: A SINGLE-CENTER REAL-WORLD EXPERIENCE
    Das, Chandan
    Prakash, Gaurav
    Bagga, Rashmi
    Rai, Bhavna
    Prasad, G. R. V.
    Saha, S. C.
    Suri, V.
    Jain, V.
    Kalra, Jaswinder
    Ghoshal, Sushmita
    Srinivasan, Radhika
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A135 - A135
  • [9] Real-World Experience Using Emicizumab Prophylaxis for Hemophilia a: Single-Center Experience
    Vagrecha, Anshul
    Stanco, Joseph
    Ulus, Daphenee
    Acharya, Suchitra
    BLOOD, 2020, 136
  • [10] REAL-WORLD EXPERIENCE FOR BIOLOGIC USE IN IBD IN THAI: A SINGLE-CENTER EXPERIENCE
    Limsrivilai, Julajak
    Chaemsupaphan, Thanaboon
    Sattayalertyanyong, Onuma
    Subdee, Nichcha
    Permpim, Parinya
    Pausawasdi, Nonthalee
    GASTROENTEROLOGY, 2023, 164 (04) : S69 - S69
12345